Are meticillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective?
- 31 May 2008
- journal article
- editorial
- Published by Elsevier in Journal of Hospital Infection
- Vol. 69 (1) , 1-5
- https://doi.org/10.1016/j.jhin.2008.01.035
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coliEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Priority setting at the micro-, meso- and macro-levels in Canada, Norway and UgandaHealth Policy, 2006
- Have targets improved performance in the English NHS?BMJ, 2006
- Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistanceJournal of Health Economics, 2005
- Methicillin-resistant–Staphylococcus aureusHospitalizations, United StatesEmerging Infectious Diseases, 2005
- Communitarian claims and community capabilities: furthering priority setting?Social Science & Medicine, 2005
- Setting priorities in health care organizations: criteria, processes, and parameters of successBMC Health Services Research, 2004
- Economics of Preventing Hospital InfectionEmerging Infectious Diseases, 2004
- The Economical Control of Infectious DiseasesThe Economic Journal, 2003
- Accountability for reasonablenessBMJ, 2000